Marketing-authorisation holder · Canada
Forus Therapeutics Inc.
2 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
2 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BESREMI500 mcg / 1 ml · Solution | Ropeginterferon alfa-2b | Canada | Marketed | 2026 |
| XPOVIO20 mg · Tablet | Selinexor | Canada | Marketed | 2022 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 2 | 2 | 0 | CompaniesAll medicines |
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- Antineoplastic agentsAntineoplastic and immunomodulating agents · ATC L01X
- ImmunostimulantsAntineoplastic and immunomodulating agents · ATC L03A